TSE:2802
TSE:2802Food

What Ajinomoto (TSE:2802)'s ADC Technology Licensing Deal With Astellas Means For Shareholders

In late October 2025, Astellas Pharma announced it has signed a licensing agreement with Ajinomoto Co., Inc. to utilize Ajinomoto's AJICAP antibody-drug conjugate (ADC) technology in its contract development and manufacturing operations for biopharmaceuticals. This partnership underscores Ajinomoto's expanding capabilities in the biopharma sector, as it leverages its proprietary technology to support the development of innovative next-generation treatments for patients. We'll examine how...
TSE:6920
TSE:6920Semiconductor

Lasertec (TSE:6920): Reviewing Valuation After New 2026 Financial Projections Boost Investor Optimism

Lasertec (TSE:6920) just released its financial projections for the year ending June 2026, giving investors an early look at what the company expects in terms of revenue and profitability for the coming period. See our latest analysis for Lasertec. Lasertec’s latest guidance sparked strong momentum, with the 1-week share price return hitting an impressive 40.6% and a 30-day return of 53.8% as investors digested upbeat forecasts and the recently announced share buyback proposal. Looking at the...
TSE:7276
TSE:7276Auto Components

How Investors May Respond To Koito Manufacturing (TSE:7276) Upwardly Revising Full-Year Earnings Guidance

On October 28, 2025, Koito Manufacturing announced an upward revision to its full-year earnings guidance for the fiscal year ending March 2026, expecting net sales to reach ¥913 billion, operating profit to total ¥45 billion, and net income per share to be ¥100.90. This update was attributed to increased global automobile production volumes and adjusted exchange rate assumptions, signaling raised confidence in future business performance. We’ll explore how Koito Manufacturing’s improved...